PaulNyirjesyMD
Obstetrics & Gynecology • Philadelphia, PAObstetrician/Gynecologist, Thomas Jefferson University Hospitals
Dr. Nyirjesy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
833 Chestnut Street
Concourse Level
Philadelphia, PA 19107Phone+1 215-955-5000
Education & Training
Temple University HospitalFellowship, Infectious Disease, 1990 - 1992
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Obstetrics and Gynecology, 1985 - 1989
Georgetown University School of MedicineClass of 1985
Certifications & Licensure
PA State Medical License 1986 - 2024- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2005-2019
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 9 citationsOral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306.Oluwatosin Goje, Ryan Sobel, Paul Nyirjesy, Steven R Goldstein, Mark Spitzer
Journal of Women's Health. 2023-02-01 - 8 citationsVulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.Paul Nyirjesy, Carolyn Brookhart, Gweneth Lazenby, Jane Schwebke, Jack D Sobel
Clinical Infectious Diseases. 2022-04-13 - 46 citationsOteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis.Jack D. Sobel, Paul Nyirjesy
Future Microbiology. 2021-11-16
Authored Content
- Physician Awareness and Adherence to Clinical Practice Guidelines in the Diagnosis of Vaginitis Patients: A Retrospective Chart ReviewOctober 2020
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Orally-Administered VT-1161 in the Treatment of Recurrent Vulvovaginal CandidiasisMarch 2018
Press Mentions
Diagnosis of Vaginitis: New Thinking for a New EraSeptember 28th, 2021- Dr. Michael William May, Ellicott City Pediatrician, DiesSeptember 16th, 2021
- Does the Candida Diet Work – and Is It Safe?June 7th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
